Disease Info Card

Atypical Adenomatous Hyperplasia

Information about Atypical Adenomatous Hyperplasia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Atypical Adenomatous Hyperplasia

Most recent studies have shown that Atypical Adenomatous Hyperplasia shares some biological mechanisms with adenocarcinoma, adenocarcinoma-of-lung-(disorder), adenoma, adenomatous-hyperplasia, bronchioloalveolar-adenocarcinoma, carcinogenesis, carcinoma, hyperplasia, intraepithelial-neoplasia, lung-neoplasms, malignant-neoplasm-of-lung, malignant-neoplasm-of-prostate, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, neoplasms, precancerous-conditions, prostatic-hyperplasia, prostatic-intraepithelial-neoplasias, prostatic-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Atypical Adenomatous Hyperplasia, and have been seen in publications frequently: Aging, Angiogenesis, Cell Adhesion, Cell Cycle, Cell Differentiation, Cell Division, Cell Migration, Cell Proliferation, Dna Hypermethylation, Dna Hypomethylation, Dna Methylation, Gene Silencing, Hyperphosphorylation, Keratinization, Localization, Methylation, Mitosis, Pathogenesis, Reverse Transcription, Secretion

Quite a number of genes have been found to play important roles in Atypical Adenomatous Hyperplasia, such as AMACR, AR, ASPH, CEACAM5, CEACAM7, CKAP4, EGFR, KLK3, KRAS, PCNA, PLAG1, PROS1, PSG2, RPE65, TP53, TP63, TSC1, UVRAG. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.